CA2331263A1 - A method of producing cells with a desired property by recursive sequence recombination - Google Patents

A method of producing cells with a desired property by recursive sequence recombination Download PDF

Info

Publication number
CA2331263A1
CA2331263A1 CA002331263A CA2331263A CA2331263A1 CA 2331263 A1 CA2331263 A1 CA 2331263A1 CA 002331263 A CA002331263 A CA 002331263A CA 2331263 A CA2331263 A CA 2331263A CA 2331263 A1 CA2331263 A1 CA 2331263A1
Authority
CA
Canada
Prior art keywords
cells
protoplasts
library
marker
desired property
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002331263A
Other languages
French (fr)
Other versions
CA2331263C (en
Inventor
Stephen Del Cardayre
Matthew Tobin
Willem P. C. Stemmer
Jon E. Ness
Jeremy Minshull
Phillip A. Patten
Venkiteswaran Subramanian
Linda A. Castle
Claus M. Krebber
Steven H. Bass
Ying-Xin Zhang
Tony Cox
Gjalt Huisman
Ling Yuan
Joseph A. Affholter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codexis Mayflower Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2720311A priority Critical patent/CA2720311A1/en
Publication of CA2331263A1 publication Critical patent/CA2331263A1/en
Application granted granted Critical
Publication of CA2331263C publication Critical patent/CA2331263C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Abstract

The invention provides methods employing iterative cycles of recombination a nd selection/screening for evolution of whole cells and organisms toward acquisition of desired properties. Examples of such properties include enhanced recombinogenicity, genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites.

Claims (42)

1. A method of producing a library of diverse multicellular organsims, the method comprising:
providing a pool of male gametes and a pool of female gametes, wherein at least one of the male pool or the female pool comprises a plurality of different gametes derived from different strains of a species or different species, wherein the male gametes fertilize the female gametes;
permitting at least a portion of the resulting fertilized gametes to grow into reproductively viable organisms;
repeatedly crossing the reproductively viable organisms to produce a library of diverse organisms; and, selecting the library for a desired trait or property.
2. The method of claim 1, wherein the library of diverse organisms comprise a plurality of plants.
3. The method of claim 2, wherein the plants are selected from: Gramineae, Fetucoideae, Poacoideae, Agrostis, Phleum, Dactylis, Sorgum, Setaria, Zea, Oryza, Triticum, Secale, Avena, Hordeum, Saccharum, Poa, Festuca, Stenotaphrum, Cynodon, Coix, Olyreae, Phareae, Compositae, and leguminosae.
4. The method of claim 2, wherein the plants are selected from corn), rice, wheat, rye, oats, barley, pea, beans, lentil, peanut, yam bean, cowpeas, velvet beans, soybean, clover, alfalfa, lupine, vetch, lotus, sweet clover, wisteria, sweetpea, sorghum, millet, sunflower, and canola.
5. The method of claim 1, wherein the library of diverse organisms comprise a plurality of animals.
6. The method of claim 5, wherein the animals are selected from non-human mammals and fish.
7. The library produced by the method of claim 1.
8. The method of claim 1, further comprising:
crossing a plurality of selected library members by pooling gametes from the selected members and repeatedly crossing any resulting additional reproductively viable organisms to produce a second library of diverse organisms; and, selecting the second library for a desired trait or property.
9. The second library made by the method of claim 8.
10. A method of evolving a cell to acquire a desired property, comprising:
(i.) forming protoplasts of a population of different cells;
(ii.) fusing the protoplasts to form hybrid protoplasts, in which genomes from the protoplasts recombine to form hybrid genomes;
(iii.) incubating the hybrid protoplasts under conditions promoting regeneration of cells, thereby producing regenerated cells;
(iv.) repeatedly forming protoplasts from the regenerated cells, fusing the protoplasts to form hybrid protoplasts, in which genomes from the protoplasts recombine to form additional hybrid genomes; incubating the additional hybrid protoplasts under conditions promoting regeneration of cells, thereby producing additional regenerated cells; and, (v.) selecting or screening to isolate regenerated cells or additionally regenerated cells that have evolved toward acquisition of the desired property.
11. The method of claim 10, wherein the desired property is selected from:
heat tolerance, ethanol production, ethanol tolerance, acid, improved production and maintenance of enzyme cofactors, improved production and maintenance of NAD(P)H, and improved glucose transport.
12. The method of claim 10, further comprising repeating steps (i.)-(v.) with regenerated cells in step (iii.) or additional regenerated cells in step (iv.) being used to form the protoplasts in step (i.) until the regenerated cells have acquired the desired property.
13. The method of claim 10, comprising step (iv), wherein step (iv). is performed prior to step (v.).
14. The method of claim 10, wherein the hybrid protoplasts comprise cells having more than two parental genomes.
15. The method of claim 10, wherein the different cells are fungal cells, and the regenerated cells are fungi mycelia.
16. The method of claim 15, wherein protoplasts are provided by treating mycelia or spores with an enzyme.
17. The method of claim 15, wherein the fungal cells are from a fragile strain, lacking capacity for intact cell wall synthesis; whereby protoplast form spontaneously.
18. The method of claim 15, further comprising treating the mycelia with an inhibitor of cell wall formation to generate protoplasts.
19. The method of claim 10, further comprising selecting or screening to isolate regenerated cells with hybrid genomes free from cells with parental genomes.
20. The method of claim 10, wherein a first subpopulation of cells contain a first marker and the second subpopulation of cells contain a second marker, and the method further comprising selecting or screening to identify regenerated cells expressing both the first and second marker.
21. The method of claim 10, wherein the first marker is a membrane marker and the second marker is a genetic marker.
22. The method of claim 10, wherein the first marker is a first subunit of a heteromeric enzyme and the second marker is a second subunit of the heteromeric enzyme.
23. The method of claim 10, fiuther comprising transforming protoplasts with a library of DNA fragments in at least one cycle.
24. The method of claim 23, wherein the DNA fragments are accompanied by a restriction enzyme.
25. The method of claim 10, further comprising exposing the protoplasts to ultraviolet irradiation in at least one cycle.
26. The method of claim 10, wherein the desired property is the expression of a protein, primary metabolite, or secondary metabolite.
27. The method of claim 10, wherein the desired property is the secretion of a protein or secondary metabolite.
28. The method of claim 27, wherein the secondary metabolite is selected from taxol, cyclosporin A, and erythromycin.
29. The method of claim 10, wherein the desired property is capacity for meiosis.
30. The method of claim 10, wherein the desired property is compatibility to form a heterokaryon with another strain.
31. The method of claim 10, further comprising exposing the protoplasts or mycelia to a mutagenic agent in at least one cycle.
32. A method for whole genome shuffling through organized heteroduplex shining, the method comprising:
(a). providing chromosomal DNA of an organism which is targeted for shuffling, digesting the chromosomal DNA with one or more restriction enzymes, ligating the chromosomal DNA into a cosmid, the cosmid comprising at least two rare restriction enzyme recognition sites, aliquoting, purifying, and storing sufficient cosmids to represent a complete chromosome;
(b). mutagenizing aliquots of the library in vitro using a mutagen;
(c). transfecting a sample from a plurality of the mutagenized aliquots into a population of target cells;
(d). assaying resulting transfectants for phenotypic improvements;
(e). growing transfected cells harboring a mutant library of the identified cosmid(s) on media and screening the resulting cell colonies for independent mutants conferring an desired phenotype;

(f). isolating and pooling DNA from cells identified in the screening;
(g). dividing the selected pools and digesting at least one sample with a rare-cutting restriction enzyme, pooling the cleaved samples, denaturing the samples, reannealing the samples and religating the samples; and, (h). transfecting target cells with the resulting heteroduplexes and propagating the cells to allow recombination to occur between the strands of the heteroduplexes in vivo.
33. The method of claim 32, further comprising additionally screening the transfectants.
34. The method of claim 32, further comprising further shuffling the heteroduplexes by recursive in vitro heteroduplex formation and in vivo recombination prior to additionally screening the transfectants.
35. The method of claim 33, further comprising performing an additional mutagenesis step to increase diversity during the shuffling process.
36. The method of claim 32, further comprising combining one or more heteroduplexes into a host chromosome by chromosome integration.
37. The method of claim 36, further comprising repeating steps (a).-(h)., using the organism resulting from chromosome integration as the source for chromosomal DNA in step (a).
38. The method of claim 32, wherein the cosmid comprises restriction sites for Sfr or NotI.
39. The method of claim 32, wherein the transfectants are assayed as a pool from each mutagenized aliquot.
40. The method of claim 32, wherein a positive assay result indicates that a cosmid from a particular aliquot can confer phenotypic improvements and contains large genomic fragments that are suitable targets for heteroduplex mediated shuffling.
41. The method of claim 32, wherein the mutagen is a chemical mutagen.
42. The method of claim 32, wherein growing transfected cells harboring a mutant library of the identified cosmid(s) on media comprises plating the transfected cells on solid media.
CA2331263A 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination Expired - Fee Related CA2331263C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2720311A CA2720311A1 (en) 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/116,188 US6326204B1 (en) 1997-01-17 1998-07-15 Evolution of whole cells and organisms by recursive sequence recombination
US09/116,188 1998-07-15
PCT/US1999/015972 WO2000004190A1 (en) 1998-07-15 1999-07-15 Evolution of whole cells and organisms by recursive sequence recombination

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2720311A Division CA2720311A1 (en) 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination

Publications (2)

Publication Number Publication Date
CA2331263A1 true CA2331263A1 (en) 2000-01-27
CA2331263C CA2331263C (en) 2011-01-18

Family

ID=22365803

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2720311A Abandoned CA2720311A1 (en) 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination
CA2331263A Expired - Fee Related CA2331263C (en) 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2720311A Abandoned CA2720311A1 (en) 1998-07-15 1999-07-15 A method of producing cells with a desired property by recursive sequence recombination

Country Status (11)

Country Link
US (6) US6326204B1 (en)
EP (2) EP1707641A3 (en)
JP (2) JP4674329B2 (en)
KR (1) KR100647112B1 (en)
AT (1) ATE317453T1 (en)
AU (1) AU771511B2 (en)
CA (2) CA2720311A1 (en)
DE (1) DE69929796T2 (en)
ES (1) ES2257866T3 (en)
IL (1) IL140121A0 (en)
WO (1) WO2000004190A1 (en)

Families Citing this family (230)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US7148054B2 (en) * 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
AU1124499A (en) 1997-10-28 1999-05-17 Maxygen, Inc. Human papillomavirus vectors
US6596539B1 (en) 1997-10-31 2003-07-22 Maxygen, Inc. Modification of virus tropism and host range by viral genome shuffling
US6146894A (en) 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
US6902918B1 (en) 1998-05-21 2005-06-07 California Institute Of Technology Oxygenase enzymes and screening method
US7153655B2 (en) 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
AU4441699A (en) 1998-06-17 2000-01-05 Maxygen, Inc. Method for producing polynucleotides with desired properties
BR9911681A (en) * 1998-08-12 2001-10-02 Maxygen Inc DNA shuffling to produce selective crops for herbicides
US6991922B2 (en) * 1998-08-12 2006-01-31 Proteus S.A. Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation
US20030104417A1 (en) * 1998-08-12 2003-06-05 Proteus S.A. Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
US6951719B1 (en) 1999-08-11 2005-10-04 Proteus S.A. Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained
US20060242731A1 (en) * 1998-08-12 2006-10-26 Venkiteswaran Subramanian DNA shuffling to produce herbicide selective crops
US20040023213A1 (en) * 1998-08-12 2004-02-05 Pangene Corporation Domain specific gene evolution
US20030092023A1 (en) * 1998-08-12 2003-05-15 Daniel Dupret Method of shuffling polynucleotides using templates
US20040191772A1 (en) * 1998-08-12 2004-09-30 Dupret Daniel Marc Method of shuffling polynucleotides using templates
US6299850B1 (en) * 1999-03-16 2001-10-09 The United States Of America As Represented By The Department Of Energy Carbon activation process for increased surface accessibility in electrochemical capacitors
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
US7033781B1 (en) 1999-09-29 2006-04-25 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
US7026119B2 (en) 2000-02-11 2006-04-11 Morphotek, Inc. Methods for generating hypermutable microbes
DE60039371D1 (en) 2000-02-18 2008-08-14 Morphotek Inc METHOD FOR THE PRODUCTION OF HYPERMUTABLE PLANTS
DE60126065T2 (en) * 2000-02-23 2007-08-30 Morphotek Inc. METHOD OF GENERATING FAST MUTIER YEAST
US6825038B2 (en) 2000-05-12 2004-11-30 The Johns Hopkins University Method for generating hypermutable organisms
US7115403B1 (en) 2000-05-16 2006-10-03 The California Institute Of Technology Directed evolution of galactose oxidase enzymes
EP1294869A2 (en) * 2000-06-14 2003-03-26 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
US20020072097A1 (en) * 2000-07-07 2002-06-13 Delcardayre Stephen Molecular breeding of transposable elements
US7435562B2 (en) 2000-07-21 2008-10-14 Modular Genetics, Inc. Modular vector systems
DK1309677T4 (en) * 2000-08-11 2012-06-25 Genencor Int Bac illustration transformation, transformants and mutant libraries
US6991786B1 (en) * 2000-08-30 2006-01-31 Wisconsin Alumni Research Foundation Anti-microbial biotherapeutic agents: alternatives to conventional pharmaceutical antibiotics
EP1319081A2 (en) * 2000-09-18 2003-06-18 Pioneer Hi-Bred International, Inc. Rice mlh1 ortholog and uses thereof
US7083945B1 (en) * 2000-10-27 2006-08-01 The Board Of Regents Of The University Of Texas System Isolation of binding proteins with high affinity to ligands
US6576468B1 (en) 2000-11-07 2003-06-10 Morphotek, Inc. Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells
US6808894B1 (en) 2000-11-07 2004-10-26 Morphotek, Inc. Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
US7223598B2 (en) * 2000-11-07 2007-05-29 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US6737268B1 (en) 2000-11-14 2004-05-18 Morphotek, Inc. Method for generating genetically altered antigens
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
US6982169B2 (en) 2001-01-15 2006-01-03 Morphotek, Inc. Chemical inhibitors of mismatch repair
ATE501251T1 (en) 2001-01-25 2011-03-15 Evolva Ltd CELL LIBRARY
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
AU2002255907A1 (en) * 2001-03-23 2002-10-08 William M. Muir Incorporation of competitive effects in breeding program to increase performance levels and improve animal well being
WO2002083868A2 (en) 2001-04-16 2002-10-24 California Institute Of Technology Peroxide-driven cytochrome p450 oxygenase variants
WO2003008563A2 (en) 2001-07-20 2003-01-30 California Institute Of Technology Improved cytochrome p450 oxygenases
US20030068808A1 (en) * 2001-07-25 2003-04-10 Nicolaides Nicholas C. Methods for generating antibiotic resistant microbes and novel antibiotics
WO2003012126A2 (en) * 2001-08-03 2003-02-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
US6943001B2 (en) * 2001-08-03 2005-09-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
US7758854B2 (en) * 2001-08-30 2010-07-20 Wisconsin Alumni Research Foundation Anti-microbial agents
US7323618B2 (en) * 2002-02-01 2008-01-29 Origen Therapeutics, Inc. Tissue specific expression of exogenous proteins in transgenic chickens
AU2003217716A1 (en) * 2002-02-25 2003-09-09 Cabot Corporation Custom ligand design for biomolecular filtration and purification for bioseperation
JP5319865B2 (en) 2002-03-01 2013-10-16 コデクシス メイフラワー ホールディングス， エルエルシー Methods, systems, and software for identifying functional biomolecules
WO2003078583A2 (en) 2002-03-09 2003-09-25 Maxygen, Inc. Optimization of crossover points for directed evolution
CN1659276A (en) 2002-04-19 2005-08-24 戴弗萨公司 Phospholipases, nucleic acids encoding them and methods for making and using them
US7226771B2 (en) 2002-04-19 2007-06-05 Diversa Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
IL164687A0 (en) 2002-05-02 2005-12-18 Univ North Carolina Cellular libraries and methods for the preparationthereof
WO2003097834A2 (en) 2002-05-17 2003-11-27 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
EP1551988B1 (en) * 2002-07-19 2010-11-24 Morphotek, Inc. Methods for generating enhanced antibody-producing cell lines with improved growth characteristics
DK1529110T3 (en) * 2002-08-01 2012-01-30 Evolva Ltd Method for mixing large numbers of heterologous genes
AU2003304275A1 (en) 2002-08-06 2005-01-21 Pioneer Hi-Bred International, Inc. Ap1 amine oxidase variants
AU2003303288B2 (en) * 2002-08-16 2006-12-07 Microchips, Inc. Controlled release device and method
US7252942B2 (en) * 2002-12-19 2007-08-07 E.I. Du Pont De Nemours And Company Parallel chromosomal stacking of traits in bacteria
DK2194133T3 (en) 2003-03-06 2016-02-29 Basf Enzymes Llc Amylases, nucleic acids encoding them, and methods of making and using the same
CA2515583C (en) 2003-03-07 2015-07-14 Diversa Corporation Hydrolases, nucleic acids encoding them and methods for making and using them
ES2545639T3 (en) 2003-04-04 2015-09-14 Basf Enzymes Llc Pectate liases, nucleic acids that encode them and methods for their preparation and use
EP1620557A2 (en) 2003-04-29 2006-02-01 Pioneer Hi-Bred International, Inc. Novel glyphosate-n-acetyltransferase (gat) genes
JP2006526990A (en) * 2003-06-06 2006-11-30 アーバージェン リミテッド ライアビリティ カンパニー Compositions and methods for modulating plant cell polysaccharides
EP1639091B1 (en) 2003-06-17 2012-12-05 California University Of Technology Regio- and enantioselective alkane hydroxylation with modified cytochrome p450
EP2404931A1 (en) 2003-07-02 2012-01-11 Verenium Corporation Glucanases, nucleic acids encoding them and methods for making and using them
US7435570B2 (en) 2003-08-11 2008-10-14 California Institute Of Technology Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
CA2535526C (en) 2003-08-11 2015-09-29 Diversa Corporation Laccases, nucleic acids encoding them and methods for making and using them
US7516086B2 (en) 2003-09-24 2009-04-07 Idearc Media Corp. Business rating placement heuristic
US7050990B1 (en) 2003-09-24 2006-05-23 Verizon Directories Corp. Information distribution system
EP1542074A1 (en) * 2003-12-11 2005-06-15 Heptagon OY Manufacturing a replication tool, sub-master or replica
WO2005081632A2 (en) * 2004-02-26 2005-09-09 State Of Israel, Ministry Of Agriculture, Agricultural Research Organization Enzymes, cells and methods for site specific recombination at asymmetric sites
US8055553B1 (en) 2006-01-19 2011-11-08 Verizon Laboratories Inc. Dynamic comparison text functionality
US20110218118A1 (en) * 2004-06-03 2011-09-08 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
ES2373397T3 (en) 2004-06-08 2012-02-03 Microbiogen Pty Ltd NON-RECOMBINANT SACCHAROMYCES STRAINS THAT GROW IN XILOSA.
ES2461857T3 (en) 2004-06-16 2014-05-21 Dsm Ip Assets B.V. Compositions and methods for enzymatic discoloration of chlorophyll
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US7799906B1 (en) 2004-09-22 2010-09-21 Arborgen, Llc Compositions and methods for modulating lignin of a plant
US7485423B2 (en) 2004-11-11 2009-02-03 Modular Genetics, Inc. Ladder assembly and system for generating diversity
US20060105375A1 (en) * 2004-11-16 2006-05-18 Bachmann Brian O Bioretrosynthetic methods for preparing products and compositions related thereto
JP2006246792A (en) * 2005-03-10 2006-09-21 Bussan Nanotech Research Institute Inc Method for detecting microorganism and bacteriolytic reagent
EP1869174B1 (en) 2005-03-10 2015-02-18 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
KR101393679B1 (en) 2005-03-15 2014-05-21 비피 코포레이션 노쓰 아메리카 인코포레이티드 Cellulases, nucleic acids encoding them and methods for making and using them
US8715988B2 (en) 2005-03-28 2014-05-06 California Institute Of Technology Alkane oxidation by modified hydroxylases
US11214817B2 (en) 2005-03-28 2022-01-04 California Institute Of Technology Alkane oxidation by modified hydroxylases
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
EP1987142A4 (en) 2006-02-02 2009-07-15 Verenium Corp Esterases and related nucleic acids and methods
EP2415864B1 (en) 2006-02-10 2014-02-12 Verenium Corporation Oligomerase-2 (or beta-xylosidase) enzymes, nucleic acids encoding them and methods for making and using them
TR201809912T4 (en) 2006-02-14 2018-07-23 Bp Corp North America Inc Xylanases, nucleic acids encoding them, and methods for making and using them.
CA2645225A1 (en) 2006-03-07 2007-09-13 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them
EP2112227B1 (en) 2006-03-07 2013-05-15 Cargill, Incorporated Aldolases, nucleic acids encoding them and methods for making and using them
BRPI0715442B1 (en) 2006-07-21 2018-01-30 Xyleco, Inc. METHOD FOR PRODUCING PRODUCTS FROM BIOMASS CELLULOSTIC OR LIGNOCELLULOSTIC MATERIAL
EP2069389B1 (en) 2006-08-04 2014-10-08 BP Corporation North America Inc. Glucanases, nucleic acids encoding them and methods for making and using them
US8026085B2 (en) 2006-08-04 2011-09-27 California Institute Of Technology Methods and systems for selective fluorination of organic molecules
US8252559B2 (en) 2006-08-04 2012-08-28 The California Institute Of Technology Methods and systems for selective fluorination of organic molecules
CA2663001A1 (en) 2006-09-21 2008-03-27 Verenium Corporation Phospholipases, nucleic acids encoding them and methods for making and using them
CA2663819C (en) 2006-09-21 2019-04-30 Verenium Corporation Phytases, nucleic acids encoding them and methods for making and using them
ES2620288T3 (en) 2006-12-21 2017-06-28 Basf Enzymes Llc Amylases and glucoamylases, nucleic acids that encode them and methods to form and use them
CA2674721C (en) 2007-01-30 2018-04-03 Verenium Corporation Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
US20090004715A1 (en) 2007-06-01 2009-01-01 Solazyme, Inc. Glycerol Feedstock Utilization for Oil-Based Fuel Manufacturing
USRE46733E1 (en) 2007-10-03 2018-02-27 Bp Corporation North America Inc. Xylanases, nucleic acids encoding them and methods for making and using them
FR2923491B1 (en) 2007-11-14 2012-12-14 Deinove Sa USE OF BACTERIA FOR THE PRODUCTION OF BIOENERGY SOURCES
WO2009068604A1 (en) 2007-11-27 2009-06-04 Vib Vzw Marker assisted directed evolution
WO2009088753A1 (en) 2008-01-03 2009-07-16 Verenium Corporation Isomerases, nucleic acids encoding them and methods for making and using them
DK2238242T5 (en) 2008-01-03 2015-08-03 Basf Enzymes Llc -Transferases and oxidoreductases, nucleic acids encoding FOR THEM, AND PROCESSES FOR THE STILL LING AND USE THEREOF
WO2009143397A2 (en) 2008-05-23 2009-11-26 E. I. Du Pont De Nemours And Company Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
MX2011003039A (en) 2008-09-26 2011-08-15 Tocagen Inc Gene therapy vectors and cytosine deaminases.
NZ596459A (en) 2009-05-21 2013-11-29 Verenium Corp Phytases, nucleic acids encoding them and methods for making and using them
DK3301208T3 (en) 2009-09-18 2020-12-14 Codexis Inc REDUCED CODON MUTAGENESIS
UA109884C2 (en) 2009-10-16 2015-10-26 A POLYPEPTIDE THAT HAS THE ACTIVITY OF THE PHOSPHATIDYLINOSYTOL-SPECIFIC PHOSPHOLIPASE C, NUCLEIC ACID, AND METHOD OF METHOD
UA111708C2 (en) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. METHOD OF OIL REFINING
CA2798937A1 (en) 2010-05-28 2011-12-01 Codexis, Inc. Pentose fermentation by a recombinant microorganism
EP2603591A1 (en) 2010-08-13 2013-06-19 Pioneer Hi-Bred International Inc. Compositions and methods comprising sequences having hydroxyphenylpyruvate dioxygenase (hppd) activity
US9322027B2 (en) 2010-08-20 2016-04-26 Shell Oil Company Expression constructs comprising fungal promoters
CN103080306B (en) 2010-08-20 2015-02-18 科德克希思公司 Use of glycoside hydrolase 61 family proteins in processing of cellulose
WO2012051055A2 (en) 2010-10-06 2012-04-19 Bp Corporation North America Inc. Variant cbh i polypeptides
CN102199624B (en) * 2011-03-24 2013-01-23 北京济福霖生物技术有限公司 Method for efficiently producing recombinant proteins in mammary glands by utilizing artificial chromosomes
EP2691517A4 (en) 2011-03-30 2015-04-22 Codexis Inc Pentose fermentation by a recombinant microorganism
BR112013033614A2 (en) 2011-06-30 2018-05-29 Codexis Inc pentose fermentation by recombinant microorganism
US9322007B2 (en) 2011-07-22 2016-04-26 The California Institute Of Technology Stable fungal Cel6 enzyme variants
DK2748317T3 (en) 2011-08-22 2017-07-17 Codexis Inc GH61 glycoside hydrolase protein variants and cofactors that enhance GH61 activity
EP2760997A4 (en) 2011-09-30 2015-02-11 Codexis Inc Fungal proteases
WO2013096244A1 (en) 2011-12-20 2013-06-27 Codexis, Inc. Endoglucanase 1b (eg1b) variants
BR112014027468A2 (en) 2012-05-04 2017-06-27 Du Pont isolated or recombinant polynucleotide, recombinant DNA construction, cell, plant, plant explant, transgenic seed, isolated polypeptide, composition, methods of producing meganuclease, introducing disruption and integrating a polynucleotide.
DK2859099T3 (en) 2012-06-11 2019-07-29 Codexis Inc MUSHROOMS-BETA-xylosidase VERSIONS
WO2014060973A1 (en) 2012-10-19 2014-04-24 Indian Oil Corporation Limited Improved microalgae strains and use thereof
EP2912169A4 (en) 2012-10-29 2016-11-23 Univ Rochester Artemisinin derivatives, methods for their preparation and their use as antimalarial agents
EP2922953A4 (en) 2012-11-20 2016-11-09 Shell Int Research Pentose fermentation by a recombinant microorganism
WO2014083534A1 (en) 2012-11-29 2014-06-05 Indian Oil Corporation Limited Mixotrophic cultivation of microalgae for the production of biofuel
GB201308828D0 (en) 2013-03-12 2013-07-03 Verenium Corp Phytase
GB201308843D0 (en) 2013-03-14 2013-07-03 Verenium Corp Phytase formulation
US20160040149A1 (en) 2013-03-14 2016-02-11 Pioneer Hi-Bred International Inc. Compositions Having Dicamba Decarboxylase Activity and Methods of Use
US20160053277A1 (en) 2013-03-14 2016-02-25 Pioneer Hi-Bred International, Inc. Compositions Having Dicamba Decarboxylase Activity and Methods of Use
CN105473605A (en) 2013-03-15 2016-04-06 先锋国际良种公司 Phi-4 polypeptides and methods for their use
CA2909719C (en) 2013-04-18 2022-09-27 Codexis, Inc. Engineered phenylalanine ammonia lyase polypeptides
SG11201600059QA (en) * 2013-07-09 2016-02-26 Harvard College Multiplex rna-guided genome engineering
AR095173A1 (en) 2013-07-25 2015-09-30 Basf Enzymes Llc FITASA
EP3032942B1 (en) 2013-08-16 2020-03-11 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
US10667524B2 (en) 2013-09-13 2020-06-02 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
WO2015048572A1 (en) 2013-09-27 2015-04-02 Codexis, Inc. Automated screening of enzyme variants
WO2015073555A1 (en) 2013-11-13 2015-05-21 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
US10544191B2 (en) 2013-12-23 2020-01-28 University Of Rochester Methods and compositions for ribosomal synthesis of macrocyclic peptides
BR112016018287A2 (en) 2014-02-07 2017-10-10 Du Pont insecticide proteins and methods for their use
CN114763376A (en) 2014-02-07 2022-07-19 先锋国际良种公司 Insecticidal proteins and methods of use thereof
US9605252B2 (en) 2014-04-16 2017-03-28 Codexis, Inc. Engineered tyrosine ammonia lyase
DK3167052T3 (en) 2014-07-09 2020-02-10 Codexis Inc P450-BM3 VARIATIONS WITH IMPROVED ACTIVITY
CN113372421A (en) 2014-10-16 2021-09-10 先锋国际良种公司 Insecticidal proteins and methods of use thereof
DK3224354T3 (en) 2014-11-25 2021-03-01 Codexis Inc MANIPULATED IMINREDUCTASES AND PROCEDURES FOR THE REDUCTIVE AMINATION OF KETONE AND AMIN COMPOUNDS
HUE062016T2 (en) 2014-12-22 2023-09-28 Codexis Inc Human alpha-galactosidase variants
US10696953B2 (en) 2015-02-10 2020-06-30 Codexis, Inc. Ketoreductase polypeptides for the synthesis of chiral compounds
BR112017019419B1 (en) 2015-03-11 2022-10-11 E. I. Du Pont De Nemours And Company DNA CONSTRUCTION, METHOD OF OBTAINING A TRANSGENIC PLANT AND METHOD TO CONTROL A CORN ROOT Worm PEST POPULATION
MX2017014213A (en) 2015-05-07 2018-03-28 Codexis Inc Penicillin-g acylases.
WO2016186986A1 (en) 2015-05-19 2016-11-24 Pioneer Hi Bred International Inc Insecticidal proteins and methods for their use
CN108271374B (en) 2015-07-07 2021-09-21 科德克希思公司 Novel P450-BM3 variants with improved activity
US11198709B2 (en) 2015-08-06 2021-12-14 E. I. Du Pont De Nemours And Company Plant derived insecticidal proteins and methods for their use
WO2017090055A1 (en) * 2015-11-25 2017-06-01 Surana Rajendra A method of producing high amount of ethanol at high temperature by modified yeast strain saccharomyces cerevisiae
US9988624B2 (en) 2015-12-07 2018-06-05 Zymergen Inc. Microbial strain improvement by a HTP genomic engineering platform
WO2017100376A2 (en) 2015-12-07 2017-06-15 Zymergen, Inc. Promoters from corynebacterium glutamicum
US11208649B2 (en) 2015-12-07 2021-12-28 Zymergen Inc. HTP genomic engineering platform
CA3007840C (en) * 2015-12-07 2020-09-15 Zymergen Inc. Microbial strain improvement by a htp genomic engineering platform
WO2017105987A1 (en) 2015-12-18 2017-06-22 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
EA201892293A1 (en) 2016-05-04 2019-04-30 Пайонир Хай-Бред Интернэшнл, Инк. INSECTICIDAL PROTEINS AND METHODS OF THEIR APPLICATION
US10724025B2 (en) 2016-05-05 2020-07-28 Codexis, Inc. Penicillin-G acylases
WO2017213758A1 (en) 2016-06-09 2017-12-14 Codexis, Inc. Biocatalysts and methods for hydroxylation of chemical compounds
BR112018075932A2 (en) 2016-06-15 2019-10-01 Codexis Inc unnaturally occurring beta-glycosidase variant, recombinant polynucleotide, vector, host cell, methods for producing at least one unnaturally occurring beta-glucosidase variant for conversion of a glycosyl group-acceptor substrate to a beta-glycosylated product and for transglycosylation of a substrate, and, composition.
EP3472186A1 (en) 2016-06-17 2019-04-24 National Hellenic Research Foundation Systems for recombinant protein production
EP3478845A4 (en) 2016-06-30 2019-07-31 Zymergen, Inc. Methods for generating a glucose permease library and uses thereof
JP2019519242A (en) 2016-06-30 2019-07-11 ザイマージェン インコーポレイテッド Method for generating a bacterial hemoglobin library and its use
EP3478052B1 (en) 2016-07-01 2021-08-25 Pioneer Hi-Bred International, Inc. Insecticidal proteins from plants and methods for their use
EP3515926B1 (en) 2016-08-26 2023-10-25 Codexis, Inc. Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
US11021716B2 (en) 2016-11-01 2021-06-01 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
CN110088123B (en) 2016-12-14 2023-10-20 先锋国际良种公司 Insecticidal proteins and methods of use thereof
CA3046226A1 (en) 2016-12-22 2018-06-28 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
KR20190102063A (en) 2017-01-05 2019-09-02 코덱시스, 인코포레이티드 Penicillin Ｇ acylase
TW202237834A (en) 2017-02-03 2022-10-01 美商克迪科思股份有限公司 Engineered glycosyltransferases and steviol glycoside glucosylation methods
US20190390219A1 (en) 2017-02-08 2019-12-26 Pioneer Hi-Bred International, Inc. Insecticidal combinations of plant derived insecticidal proteins and methods for their use
JP2020505942A (en) 2017-02-13 2020-02-27 コデクシス， インコーポレイテッド Phenylalanine ammonia lyase polypeptide
US11021729B2 (en) 2017-04-27 2021-06-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
CA3062550A1 (en) 2017-05-08 2018-11-15 Codexis, Inc. Engineered ligase variants
US11555203B2 (en) 2017-05-11 2023-01-17 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
EP3635110A2 (en) * 2017-06-06 2020-04-15 Zymergen, Inc. A high-throughput (htp) genomic engineering platform for improving saccharopolyspora spinosa
CN110945125A (en) * 2017-06-06 2020-03-31 齐默尔根公司 HTP genetic engineering modification platform for improving escherichia coli
EP3638688A4 (en) 2017-06-14 2021-07-07 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
CN111051506B (en) 2017-06-27 2023-11-24 科德克希思公司 Penicillin G acylase
CA3066767A1 (en) 2017-06-30 2019-01-03 Codexis, Inc. T7 rna polymerase variants
CN111032863A (en) 2017-06-30 2020-04-17 科德克希思公司 T7RNA polymerase variants
WO2019036202A1 (en) * 2017-08-17 2019-02-21 Cargill, Incorporated Genetically modified haploid issatchenkia orientalis
WO2019040335A1 (en) 2017-08-19 2019-02-28 University Of Rochester Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents
ES2704201B2 (en) * 2017-09-14 2019-11-18 Tomsa Destil S L Saccharomyces cerevisiae strain and its use for the elaboration of alcoholic products
EP3706780A4 (en) 2017-11-07 2021-12-22 Codexis, Inc. Transglutaminase variants
MX2020006222A (en) 2017-12-13 2020-08-31 Codexis Inc Carboxyesterase polypeptides for amide coupling.
EP3794116A2 (en) 2018-05-17 2021-03-24 BP Corporation North America Inc. Production of 2-keto-3-deoxy-d-gluconic acid in filamentous fungi
WO2019241132A1 (en) 2018-06-12 2019-12-19 Codexis, Inc. Engineered tyrosine ammonia lyase
SG11202012107RA (en) 2018-07-09 2021-01-28 Codexis Inc Engineered deoxyribose-phosphate aldolases
MX2021000328A (en) 2018-07-09 2021-03-25 Codexis Inc Engineered galactose oxidase variant enzymes.
MX2021000322A (en) 2018-07-09 2021-03-25 Codexis Inc Engineered phosphopentomutase variant enzymes.
SG11202012111UA (en) 2018-07-09 2021-01-28 Codexis Inc Engineered purine nucleoside phosphorylase variant enzymes
CN112673091A (en) 2018-07-09 2021-04-16 科德克希思公司 Engineered pantothenate kinase variant enzymes
CN112672989A (en) 2018-07-12 2021-04-16 科德克希思公司 Engineered phenylalanine ammonia lyase polypeptides
KR20210040408A (en) 2018-07-30 2021-04-13 코덱시스, 인코포레이티드 Engineered glycosyltransferase and steviol glycoside glucosylation method
AU2019334672A1 (en) 2018-09-07 2021-03-25 Basf Plant Science Company Gmbh Improved method for the production of high levels of PUFA in plants
US20230183728A1 (en) 2018-09-07 2023-06-15 Basf Plant Science Company Gmbh Improved method for the production of high levels of pufa in plants
EP3847263A1 (en) 2018-09-07 2021-07-14 Basf Plant Science Company GmbH Improved method for the production of high levels of pufa in plants
WO2020092216A1 (en) 2018-10-29 2020-05-07 Codexis, Inc. Engineered dna polymerase variants
AU2019397401A1 (en) 2018-12-14 2021-06-17 Codexis, Inc. Engineered tyrosine ammonia lyase
CA3123598A1 (en) 2018-12-20 2020-06-25 Codexis, Inc. Human alpha-galactosidase variants
BR112022011895A2 (en) 2019-12-20 2022-09-06 Basf Se DECREASE IN TERPENE TOXIDITY AND INCREASED POTENTIAL PRODUCTION IN MICROORGANISMS
CN115427557A (en) 2020-04-10 2022-12-02 科德克希思公司 Engineered transaminase polypeptides
AU2021285040A1 (en) 2020-06-04 2023-01-05 Isobionics B.V. Synthetic santalene synthases
CN111513024A (en) * 2020-06-19 2020-08-11 宁夏绿方水产良种繁育有限公司 Soft-shelled turtle breeding method capable of increasing survival rate
BR112022027035A2 (en) 2020-07-14 2023-04-11 Pioneer Hi Bred Int INSECTICIDAL PROTEINS AND METHODS FOR THE USE OF THEM
EP4204552A1 (en) 2020-08-28 2023-07-05 Codexis, Inc. Engineered amylase variants
EP4015626A1 (en) 2020-12-18 2022-06-22 Isobionics B.V. Enzymes and methods for fermentative production of monoterpene esters
EP4262804A2 (en) 2020-12-18 2023-10-25 Codexis, Inc. Engineered uridine phosphorylase variant enzymes
WO2022212824A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered adenylate kinase variant enzymes
CA3214975A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered cyclic gmp-amp synthase (cgas) variant enzymes
IL305928A (en) 2021-04-02 2023-11-01 Codexis Inc Engineered acetate kinase variant enzymes
CA3214973A1 (en) 2021-04-02 2022-10-06 Codexis, Inc. Engineered guanylate kinase variant enzymes
CN117795087A (en) 2021-08-02 2024-03-29 巴斯夫欧洲公司 Novel production of aromatic compounds with violet subunit ethane synthase
WO2023173084A1 (en) 2022-03-11 2023-09-14 University Of Rochester Cyclopeptibodies and uses thereof
WO2024040020A1 (en) 2022-08-15 2024-02-22 Absci Corporation Quantitative affinity activity specific cell enrichment

Family Cites Families (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163880A (en) 1978-04-26 1979-12-26 Glaxo Group Ltd Improvement in cephalosporin production
CA1220733A (en) * 1982-12-27 1987-04-21 Shigeru Takahashi Method for promoting fusion of plant protoplast
HU194306B (en) 1983-05-16 1988-01-28 Gyogyszerkutato Intezet Process for influencing biosynthesis of antibiotics with in vivo genetical recombination
US4940834A (en) 1983-12-05 1990-07-10 Lofts, Inc. Plants having endophytio-fungus-enhanced performance and method of producing same
DE3588239T3 (en) 1985-03-30 2007-03-08 Kauffman, Stuart A., Santa Fe A method for obtaining DNA, RNA, peptides, polypeptides or proteins by DMS recombinant methods
US6492107B1 (en) 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US5824469A (en) 1986-07-17 1998-10-20 University Of Washington Method for producing novel DNA sequences with biological activity
US4940839A (en) * 1986-10-01 1990-07-10 Dna Plant Technology Corporation Method of tomato protoplast fusion and regeneration of hybrid plants therefrom
US4889806A (en) 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
DE3889546T2 (en) 1987-12-21 1994-09-08 Univ Toledo TRANSFORMATION OF Germinating PLANT SEEDS WITH THE HELP OF AGROBACTERIUM.
FR2641793B1 (en) 1988-12-26 1993-10-01 Setratech METHOD OF IN VIVO RECOMBINATION OF DNA SEQUENCES HAVING BASIC MATCHING
DD282028A5 (en) 1989-02-16 1990-08-29 Akad Wissenschaften Ddr PROCESS FOR PREPARING THERMOSTABILES, HYBRIDEN BACILLUS BETA-1,3-1,4-GLUCANASE
JP2855130B2 (en) 1989-07-19 1999-02-10 吉富製薬株式会社 Fusion yeast for expressing heterologous protein, method for producing the same, and method for producing heterologous protein
AU633958B2 (en) 1989-07-25 1993-02-11 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
US5574205A (en) 1989-07-25 1996-11-12 Cell Genesys Homologous recombination for universal donor cells and chimeric mammalian hosts
US5426040A (en) * 1989-08-17 1995-06-20 Northeastern University Methods for producing improved strains of seaweed by fusion of spore-protoplasts, and resultant seaweeds and phycocolloids
ES2164634T3 (en) 1989-10-18 2002-03-01 Us Health PRODUCTION AND USE OF HUMAN NM23-H2 PROTEIN AND ANTIBODIES INTENDED TO SUCH EFFECT.
KR100233781B1 (en) 1989-11-06 1999-12-01 스테펜 에이. 쉐어윈 Production of proteins using homologous recombination
US5877402A (en) 1990-05-01 1999-03-02 Rutgers, The State University Of New Jersey DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein
WO1992003917A1 (en) 1990-08-29 1992-03-19 Genpharm International Homologous recombination in mammalian cells
WO1992017598A1 (en) * 1991-03-29 1992-10-15 The Board Of Trustees Of The University Of Illinois Production fo transgenic soybean plants
US5512463A (en) 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US5514568A (en) 1991-04-26 1996-05-07 Eli Lilly And Company Enzymatic inverse polymerase chain reaction
US6071889A (en) 1991-07-08 2000-06-06 Neurospheres Holdings Ltd. In vivo genetic modification of growth factor-responsive neural precursor cells
US5843643A (en) 1992-02-21 1998-12-01 Ratner; Paul L. Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid
WO1993019170A1 (en) 1992-03-16 1993-09-30 Jacob Nathaniel Wohlstadter Selection methods
US5763240A (en) 1992-04-24 1998-06-09 Sri International In vivo homologous sequence targeting in eukaryotic cells
JPH07506252A (en) 1992-04-24 1995-07-13 エス・アール・アイ・インターナシヨナル In vivo homologous sequence targeting in eukaryotic cells
DE4319496A1 (en) 1992-06-17 1994-04-07 Sandoz Ag Mushrooms for the reduction of the resin content and their extraction
WO1995003400A1 (en) 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
US5643745A (en) 1994-02-03 1997-07-01 University Of Hawaii Heterologous dimeric proteins produced in heterokaryons
US5683899A (en) 1994-02-03 1997-11-04 University Of Hawaii Methods and compositions for combinatorial-based discovery of new multimeric molecules
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5521077A (en) 1994-04-28 1996-05-28 The Leland Stanford Junior University Method of generating multiple protein variants and populations of protein variants prepared thereby
US5605820A (en) 1994-06-23 1997-02-25 Chemgenics Pharmaceuticals, Inc. Production of strains having biological activities by sexual crosses between vegetatively incompatible strains of Aspergillus nidulans
US5514588A (en) 1994-12-13 1996-05-07 Exxon Research And Engineering Company Surfactant-nutrients for bioremediation of hydrocarbon contaminated soils and water
AU723619B2 (en) 1995-04-24 2000-08-31 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US6004788A (en) 1995-07-18 1999-12-21 Diversa Corporation Enzyme kits and libraries
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
US6030779A (en) 1995-07-18 2000-02-29 Diversa Corporation Screening for novel bioactivities
US6168919B1 (en) 1996-07-17 2001-01-02 Diversa Corporation Screening methods for enzymes and enzyme kits
DE69620766T2 (en) 1995-08-11 2004-11-18 Novozymes A/S METHOD FOR THE PRODUCTION OF POLYPEPTIDE COMBS
US5962258A (en) 1995-08-23 1999-10-05 Diversa Corporation Carboxymethyl cellulase fromthermotoga maritima
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US6489145B1 (en) 1996-07-09 2002-12-03 Diversa Corporation Method of DNA shuffling
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US5962283A (en) 1995-12-07 1999-10-05 Diversa Corporation Transminases and amnotransferases
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US6171820B1 (en) 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US5814473A (en) 1996-02-09 1998-09-29 Diversa Corporation Transaminases and aminotransferases
US5773221A (en) 1995-12-15 1998-06-30 Oceanix Biosciences Corporation Method of recovering a biological molecule from a recombinant microorganism
EP0873398B1 (en) 1996-01-10 2005-04-20 Novozymes A/S A method for in vivo production of a mutant library in cells
US5942430A (en) 1996-02-16 1999-08-24 Diversa Corporation Esterases
US5958751A (en) 1996-03-08 1999-09-28 Diversa Corporation α-galactosidase
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US5783431A (en) 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
US5789228A (en) 1996-05-22 1998-08-04 Diversa Corporation Endoglucanases
US5877001A (en) 1996-06-17 1999-03-02 Diverso Corporation Amidase
US5763239A (en) 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
WO1997048416A1 (en) 1996-06-19 1997-12-24 Recombinant Biocatalysis, Inc. Thermostable phosphatases
US5939300A (en) 1996-07-03 1999-08-17 Diversa Corporation Catalases
AU6487196A (en) 1996-07-09 1998-02-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Transformation-associated recombination cloning
US5869718A (en) 1996-07-15 1999-02-09 Julien; Jean-Pierre Homologous recombination for animal model exhibiting reduced levels or elimination of a neuronal intermediate filament protein
US6093873A (en) 1996-08-19 2000-07-25 Institut National De La Sante Et De La Recherche Medicale Genetically engineered mice containing alterations in the gene encoding RXR
US6173410B1 (en) 1996-08-21 2001-01-09 Texas Instruments Incorporated Microprocessor circuits, systems and methods for conditioning information prefetching based on resource burden
CA2268265A1 (en) 1996-09-27 1998-04-02 Maxygen, Inc. Methods for optimization of gene therapy by recursive sequence shuffling and selection
WO1998013487A1 (en) 1996-09-27 1998-04-02 Maxygen, Inc. Methods for optimization of gene therapy by recursive sequence shuffling and selection
ATE295850T1 (en) 1996-12-06 2005-06-15 Diversa Corp GLYCOSIDASE ENZYMES
WO1998028416A1 (en) 1996-12-20 1998-07-02 Novo Nordisk A/S In vivo recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP1007732B1 (en) 1997-01-17 2006-07-26 Maxygen, Inc. EVOLUTION OF procaryotic WHOLE CELLS BY RECURSIVE SEQUENCE RECOMBINATION
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US5929250A (en) 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
CA2281931A1 (en) 1997-02-13 1998-08-20 The Dow Chemical Company Recombinant haloaliphatic dehalogenases
US6387862B2 (en) 1997-03-07 2002-05-14 The Procter & Gamble Company Bleach compositions
DE69839668D1 (en) 1997-03-18 2008-08-14 Novozymes As An In Vitro Method for Making a DNA Library
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
US6159687A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods for generating recombined polynucleotides
ATE468394T1 (en) 1997-03-18 2010-06-15 Novozymes As MIXING OF HETEROLOGUE DNA SEQUENCES
DE69840382D1 (en) 1997-03-18 2009-02-05 Novozymes As METHOD FOR THE PRODUCTION OF A LIBRARY THROUGH DNA SHUFFLING
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
BR9804857A (en) 1997-04-22 1999-08-24 Gist Brocades Bv Process for the fermentative production of deacylated cephalosporins
US6051049A (en) 1997-05-29 2000-04-18 Exothermic Distribution Corporation Utilization of strontium aluminate in steelmaking
US5948666A (en) 1997-08-06 1999-09-07 Diversa Corporation Isolation and identification of polymerases
US5876997A (en) 1997-08-13 1999-03-02 Diversa Corporation Phytase
US6610528B1 (en) 1997-08-26 2003-08-26 Diversa Corporation Microbial enrichment using a container having a plurality of solid support particles
AU9374298A (en) 1997-09-12 1999-04-05 Oceanix Biosciences Corporation Preparation and use of biofilm-degrading, multiple-specificit y, hydrolytic enzyme mixtures
US6846627B2 (en) 1997-10-15 2005-01-25 Diversa Corporation Screening for novel compounds which regulate biological interactions
AU1124499A (en) 1997-10-28 1999-05-17 Maxygen, Inc. Human papillomavirus vectors
US6596539B1 (en) 1997-10-31 2003-07-22 Maxygen, Inc. Modification of virus tropism and host range by viral genome shuffling
US6232112B1 (en) 1997-11-24 2001-05-15 Flinders Technologies Pty Ltd Of Flinders University Reagents and methods for diversification of DNA
WO1999041368A2 (en) 1998-02-11 1999-08-19 Maxygen, Inc. Optimization of immunomodulatory properties of genetic vaccines
AU3289199A (en) 1998-02-11 1999-08-30 Maxygen, Inc. Antigen library immunization
AU744699B2 (en) 1998-03-04 2002-02-28 Verenium Corporation Production and use of normalized DNA libraries
CN1314911A (en) 1998-05-01 2001-09-26 麦克西根股份有限公司 Optimization of pest resistance genes using DNA shuffling
AU4441699A (en) 1998-06-17 2000-01-05 Maxygen, Inc. Method for producing polynucleotides with desired properties
EP2253704B1 (en) 1999-01-19 2015-08-19 Codexis Mayflower Holdings, LLC Oligonucleotide mediated nucleic acid recombination
US6030267A (en) 1999-02-19 2000-02-29 Micron Technology, Inc. Alignment method for field emission and plasma displays
IL145165A0 (en) 1999-03-09 2002-06-30 Diversa Corp End selection in directed evolution
CA2329122A1 (en) 1999-03-26 2000-10-05 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution

Also Published As

Publication number Publication date
JP2002520071A (en) 2002-07-09
US6528311B1 (en) 2003-03-04
US6335198B1 (en) 2002-01-01
KR20010083053A (en) 2001-08-31
ATE317453T1 (en) 2006-02-15
US8377681B2 (en) 2013-02-19
JP4674329B2 (en) 2011-04-20
US6716631B1 (en) 2004-04-06
WO2000004190A1 (en) 2000-01-27
CA2720311A1 (en) 2000-01-27
AU5102699A (en) 2000-02-07
DE69929796T2 (en) 2006-10-12
AU771511B2 (en) 2004-03-25
US20120252681A1 (en) 2012-10-04
US6326204B1 (en) 2001-12-04
EP1108058A1 (en) 2001-06-20
EP1707641A2 (en) 2006-10-04
WO2000004190A9 (en) 2000-08-10
EP1108058B1 (en) 2006-02-08
US6287862B1 (en) 2001-09-11
JP2010131014A (en) 2010-06-17
CA2331263C (en) 2011-01-18
EP1108058A4 (en) 2003-03-05
KR100647112B1 (en) 2006-11-17
DE69929796D1 (en) 2006-04-20
EP1707641A3 (en) 2006-12-27
ES2257866T3 (en) 2006-08-01
IL140121A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
CA2331263A1 (en) A method of producing cells with a desired property by recursive sequence recombination
Meinke Genome‐wide identification of EMBRYO‐DEFECTIVE (EMB) genes required for growth and development in Arabidopsis
Li et al. An indexed, mapped mutant library enables reverse genetics studies of biological processes in Chlamydomonas reinhardtii
Idnurm et al. A silver bullet in a golden age of functional genomics: the impact of Agrobacterium-mediated transformation of fungi
EP1717322B1 (en) Evolution of whole cells and organisms by recursive sequence recombination
JP7227162B2 (en) HTP Genome Engineering Platform for Improving Fungal Strains
Sauer Evolutionary engineering of industrially important microbial phenotypes
Baker et al. Two polyketide synthase-encoding genes are required for biosynthesis of the polyketide virulence factor, T-toxin, by Cochliobolus heterostrophus
Qi et al. Genome editing enables next-generation hybrid seed production technology
Nelson et al. Targeted disruption of the NIT8 gene in Chlamydomonas reinhardtii
Crook et al. Classical strain improvement
Akada et al. Construction of recombinant sake yeast containing a dominant FAS2 mutation without extraneous sequences by a two-step gene replacement protocol
Kawano et al. Polymorphism and uniparental inheritance of mitochondrial DNA in Physarum polycephalum
US6232112B1 (en) Reagents and methods for diversification of DNA
Lloyd Crossover patterning in plants
Klar et al. SUM1, an apparent positive regulator of the cryptic mating-type loci in Saccharomyces cerevisiae
EP1242593B1 (en) A functional gene array in yeast
Huang et al. Disruption of six novel yeast genes reveals three genes essential for vegetative growth and one required for growth at low temperature
Randez-Gil et al. Construction of industrial baker's yeast strains able to assimilate maltose under catabolite repression conditions
Nakamura et al. Strict paternal transmission of mitochondrial DNA of Chlamydomonas species is explained by selection against maternal nucleoids
CN113980905B (en) In vitro cell platform for pig gene editing sgRNA screening
CA1305679C (en) Efficient riboflavin production with yeast
Anderson et al. Regulation of development by the matA complex locus in Physarum polycephalum
Li et al. High-throughput genetics strategies for identifying new components of lipid metabolism in the green alga Chlamydomonas reinhardtii
Silberstein et al. Mutant with heat-sensitive capacity for phagocytosis in tetrahymena: isolation and genetic characterization

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170717